Cangrelor
Cangrelor (AR-C69931MX), an adenosine triphosphate analogue, is an intravenous, reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor directly blocks adenosine diphosphate (ADP) -induced activation and aggregation of platelets. Cangrelor is also a nonspecific GPR17 antagonist[1][2].
Product Specifications
CAS Number
163706-06-7
Product Name Alternative
AR-C69931MX
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cangrelor.html
Solubility
10 mM in DMSO
Smiles
CSCCNC1=C2C(N([C@H]3[C@H](O)[C@H](O)[C@@H](COP(OP(C(Cl)(Cl)P(O)(O)=O)(O)=O)(O)=O)O3)C=N2)=NC(SCCC(F)(F)F)=N1
Molecular Formula
C17H25Cl2F3N5O12P3S2
Molecular Weight
776.36
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
P2Y12 Receptor
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1), partial
Recombinant Human Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1), partial
Recombinant Human Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1), partial